Healthcare
Innogest, Invitalia in €8.4m series-A for GreenBone Ortho
Luxembourg-based investment holding Helsinn Group led the funding round with a €2m injection
TVM leads €25m series-A for Centogene
Backers include Deutsche Private Equity, Careventures and CIC Capital
Medicxi launches £300m late-stage fund
New vehicle will invest тЌ10-25m in private or public European biotechnology businesses
Intera-backed Silmäasema raises €35m in IPO
Company will raise тЌ35m from the offering, while the sellers, including Intera, will reap тЌ30m
Charterhouse takes majority stake in Serb
Deal will be the first ever buyout for the Belgian speciality pharmaceuticals group
Eurazeo PME to acquire 80% of In'Tech Medical for €78m
Eurazeo is taking over from TCR Capital, which had secured a majority stake in In'Tech in 2012
Hartenberg's FutureLife bolts on Galway
FutureLife acquired the business through its subsidiary ReproMed, which the group bought in 2016
Enterprise Investors completes exit of PBKM
Following the initial float, the GP has fully exited the asset after an eight-year holding period
TA invests in Biocomposites
GP is currently investing from its $5.3bn 12th fund, which held a final close in 2015
PAI to sell DomusVi to ICG and SRS
GP will fully exit the investment to ICG and SRS after three years of ownership
Pemberton arranges refinancing for Capvis-backed Ondal
Approximately 20% of the €1.2bn debt vehicle is now deployed in Germany, according to the firm
EQT sells stake in Swiss Smile to Jacobs Holding
Swiss Smile has nearly doubled its revenues from CHF 3.9bn under EQT's stewardship
Ufenau buys Altano to consolidate equine clinics market
Fund manager says it has already started exclusive negotiations with several regional competitors
Nordic Capital and Avista in partial exit for ConvaTec
Sale is understood to have generated ТЃ805m in gross proceeds for the private equity owners
Intera-backed Silmäasema IPO oversubscribed multiple times
SilmУЄasema announced a price range of тЌ6.20-7.20 on 26 May, implying a market cap of тЌ92-105m
Waterland-backed Median buys two rehab clinics
Waterland injected a seven-figure sum of extra capital into Median to finance the transaction
VC-backed Bicycle Therapeutics raises £40m series-B
Round is led by new backer Vertex Ventures and includes several existing investors
InfraVia buys Irish nursing homes operator Carechoice
GP recently closed its third European infrastructure fund, InfraVia European Fund III, on тЌ1bn
G Square sells Mikeva for €150m
Paris-based private equity firm fully exits the asset after a five-year holding period
Merck leads CHF 10.5m series-A for Inthera Bioscience
Aglaia Biomedical Ventures and Novo Seeds also participated in the round alongside an unnamed private investor
European Capital provides €26m unitranche in Moria refinancing
Bridgepoint Development Capital became Moria's new majority owner in 2014 as it took over the EdRCP group
Principia leads €6.5m series-B for neurology firm Wise
Existing investors Atlante Ventures, High-Tech Gründerfonds, F3F and Antares join the round
NPM Capital sells Samenwerkende to trade
GP sells its holding in the Dutch dental practices chain after six years of ownership
NVM divests Kirton to NorthEdge's Direct Healthcare
Acquisition of the medical seating company is the second bolt-on made by Direct Healthcare under NorthEdge